| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 08/24/2004 | US6780970 Peptides for use in the treatment and prevention of diabetes, reperfusion injuries, immunological, cardiovascular and autoimune diseases |
| 08/24/2004 | US6780888 Fat-soluble and stable silicon-containing derivatives of ascorbic acid |
| 08/24/2004 | US6780874 Autoimmune disease; antiinflammatory agents; antiproliferative agent |
| 08/24/2004 | US6780870 Treatment of the pain (both chronic and acute), fever and inflammation of a variety of conditions and diseases mediated by cox-2 |
| 08/24/2004 | US6780869 Selective inhibitor of cox-2; antiinflammatory agent |
| 08/24/2004 | US6780849 Nitric-oxide releasing lipid molecules selected from phosphoglycerides, lipids having a sphingosine base as a backbone, a monoglyceride, a diglyceride, a glycosylacylglycerol and a sterol containing s-n=o, n-n=o or |
| 08/24/2004 | US6780836 Treating infection or ischemic wound in a mammal by administering relaxin, a hormone which induces secretion of vascular endothelial growth factor (vegf) |
| 08/24/2004 | US6780626 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 08/19/2004 | WO2004070050A2 Cyclic urea derivatives, preparation method thereof and pharmaceutical use of same as kinase inhibitors |
| 08/19/2004 | WO2004069871A1 Growth factor complexes and modulation of cell migration and growth |
| 08/19/2004 | WO2004069798A1 Melanin-concentrating hormone receptor antagonists containing piperidine derivatives as the active ingredient |
| 08/19/2004 | WO2004069797A1 Novel heteroaryl-substituted acetone derivatives as inhibitors of phospholipase a2 |
| 08/19/2004 | WO2004069788A1 Carboxylic acid compounds |
| 08/19/2004 | WO2004069338A1 Use of combinations of h1 and h3 histamine receptor antagonists for the preparation of a medicament for the treatment of allergic skin and allergic ocular conditions |
| 08/19/2004 | WO2004069276A1 Drug for preventing, regulating or treating adhesion |
| 08/19/2004 | WO2004069267A1 Pharmaceutical combinations comprising corticoids and immunosuppressants for treating corticoid- and/or calcineurin inhibitors-resistant diseases |
| 08/19/2004 | WO2004069247A1 Topical immunotherapy and compositions for use therein |
| 08/19/2004 | WO2004069213A2 Cosmetic composition comprising a 2-alkylideneaminooxyacetamide |
| 08/19/2004 | WO2004069142A2 Anti-candida agents for the treatment of prion diseases |
| 08/19/2004 | WO2004069134A2 Invert emulsion type composition containing at least one active agent sensitive to the presence of water, and its uses in cosmetics and in dermatology |
| 08/19/2004 | WO2004068931A2 Amphiregulin antibodies and their use to treat cancer and psoriasis |
| 08/19/2004 | WO2004058282A3 Method of obtaining a soothing active ingredient, active ingredient and compositions obtained |
| 08/19/2004 | WO2003063851A8 Composition for pharmaceutical or dietetic use for combating hair loss |
| 08/19/2004 | WO2003057134A8 Specific binding agents of human angiopoietin-2 |
| 08/19/2004 | WO2003049702A8 Vanilloid receptor ligands and their use in treatments |
| 08/19/2004 | US20040162433 Lipoxin A4 analogs |
| 08/19/2004 | US20040162426 TNF (tumor necrosis factor); for treating conditions such as rheumatoid and osteoarthritis, corneal, epidermal or gastric ulceration; tumor metastasis or invasion; periodontal disease and bone disease |
| 08/19/2004 | US20040162339 such as 3-[3-(1-adamantyl)-4-methoxyphenyl]-3-methyl-2H-1-benzofuran-6-carboxylic acid for treatment of psoriasis, dermatitis, acne or seborrhoea; veterinary medicine |
| 08/19/2004 | US20040162328 Compounds of the family of 3-alkyl-(4,5-diphenyl-imidazol-1-yl) and their use as soothing agents |
| 08/19/2004 | US20040162314 Enzyme inhibitors of phosphordiesterase 4 having minimal side effects; antiinflammatory agents; antiallergens; asthma; neurodegenerative disorders; antidiabetic agents; pain; anti-tumor, -carcinogenic and -arthritic agents |
| 08/19/2004 | US20040162301 Minoxidil-containing liquid composition |
| 08/19/2004 | US20040162287 Substituted cyclohexane-1,4-diamine compounds |
| 08/19/2004 | US20040162257 For inhibiting angiogenesis |
| 08/19/2004 | US20040162251 Pharmaceutical composition containing decoy and method of using the same |
| 08/19/2004 | US20040161814 for drug screening enzyme inhibitors using gel chromatography; bioassays; gene therapy; genetic engineering |
| 08/19/2004 | US20040161393 Dual inhibitors of cholesteryl ester and wax ester synthesis for sebaceous gland disorders |
| 08/19/2004 | DE10237722A1 Indol- oder Benzimidazolderivate zur Modulation der IKappaB-Kinase Indole or benzimidazole derivatives for the modulation of IkappaB kinase |
| 08/19/2004 | DE10144235B4 W/S-Emulsionen und deren Verwendung W / S emulsions and their use |
| 08/19/2004 | CA2515717A1 Melanin-concentrating hormone receptor antagonists containing piperidine derivatives as the active ingredient |
| 08/19/2004 | CA2515516A1 Carboxylic acid compounds |
| 08/19/2004 | CA2515335A1 Growth factor complexes and modulation of cell migration and growth |
| 08/19/2004 | CA2515147A1 Novel heteroaryl-substituted acetone derivatives as inhibitors of phospholipase a2 |
| 08/19/2004 | CA2515081A1 Amphiregulin antibodies and their use to treat cancer and psoriasis |
| 08/19/2004 | CA2513731A1 Pharmaceutical combinations comprising corticoids and immunosuppressants for treating corticoid- and/or calcineurin inhibitors-resistant diseases |
| 08/19/2004 | CA2513631A1 Cyclic urea derivatives, preparation method thereof and pharmaceutical use of same as kinase inhibitors |
| 08/18/2004 | EP1447401A1 Piperidin-2-one derivative compounds and drugs containing these compounds as the active ingredient |
| 08/18/2004 | EP1447094A1 Remedies for pruritus |
| 08/18/2004 | EP1446500A2 A method for regulating immune function in primates using the foxp3 protein |
| 08/18/2004 | EP1446487A1 Mammalian protein phosphatases |
| 08/18/2004 | EP1446413A1 Synthesis of 2-aralkoxy adenosines and 2-alkoxyadenosines |
| 08/18/2004 | EP1446407A2 (pyrido/thieno)-(f)-oxazepin-5-one derivatives as positive modulators of the ampa receptor |
| 08/18/2004 | EP1446405A2 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto |
| 08/18/2004 | EP1446394A1 NOVEL 1,2,4−THIADIAZOLE DERIVATIVES AS MELANOCORTIN RECEPTOR MODULATORS |
| 08/18/2004 | EP1446393A1 2-amino-thiazoline derivatives and their use as inhibitors of inducible no-synthase |
| 08/18/2004 | EP1446382A1 Anthranilic acid amides and their use as vegf receptor tyrosine kinase inhibitors |
| 08/18/2004 | EP1446381A1 Anthranilic acid amides and pharmaceutical use thereof |
| 08/18/2004 | EP1446150A1 Pharmaceutical composition comprising factor vii polypeptides and protein c inhibitors |
| 08/18/2004 | EP1446146A1 Pharmaceutical composition comprising factor vii polypeptides and pai-1 polypeptides |
| 08/18/2004 | EP1446136A2 Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 |
| 08/18/2004 | EP1446134A1 Compositions comprising organic extracts of geum japonicum thunb var. and the use thereof |
| 08/18/2004 | EP1446113A2 Compounds and methods for treating transplant rejection |
| 08/18/2004 | EP1446096A1 Topical compositions containing enzymes stabilised with inhibitors |
| 08/18/2004 | EP1446088A2 Intraorally disintegrating valdecoxib compositions prepared by fluid bed granulation process |
| 08/18/2004 | EP1446086A1 Compositions containing oils having a specific gravity higher than the specific gravity of water |
| 08/18/2004 | EP1446015A1 Remodeling of tissues and organs |
| 08/18/2004 | EP1345585A4 Compositions for prevention and alleviation of skin wrinkles |
| 08/18/2004 | EP1315504B1 1alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol and its therapeutic applications |
| 08/18/2004 | EP1194109B1 Topical formulations comprising skin penetration agents and the use thereof |
| 08/18/2004 | EP1187814B1 5-phenyl-pyrimidine derivatives |
| 08/18/2004 | EP1152744B1 Skin sanitizing compositions |
| 08/18/2004 | EP1011610A4 Skin care compositions and use |
| 08/18/2004 | EP0944599B1 Triarylethanes useful as pde iv inhibitors |
| 08/18/2004 | EP0881914B1 Methoxyethoxy oligonucleotides for modulation of protein kinase c expression |
| 08/18/2004 | EP0871730B1 Combination pdgf, kgf, igf and igfbp for wound healing |
| 08/18/2004 | CN1522263A Novel galactosylceramide analogs and beta-glucocerebrosidase activators, external skin preparations and method of activating beta-glucocerebrosidase using the analogs |
| 08/18/2004 | CN1522258A Novel 4-amino-5,6-substituted thiopheno 2,3-d]pyrimidines |
| 08/18/2004 | CN1522254A Immunomodulating compounds |
| 08/18/2004 | CN1522150A Agent containing fat (oil), which contains onion extract, the production and use thereof for caring, preventing or treating damaged skin tissue, especially scarred tissue |
| 08/18/2004 | CN1522146A Use of cyclopamine in the treatment of psoriasis |
| 08/18/2004 | CN1522143A Coenzyme q and eicosapentaenoic acid (epa) |
| 08/18/2004 | CN1522136A Hair lotion stimulating hair growth |
| 08/18/2004 | CN1522135A Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
| 08/18/2004 | CN1520870A Chinese herbal medicine for treating tinea versicolor |
| 08/18/2004 | CN1520866A Traditional Chinese medicine compound ointment for children dermatosis |
| 08/18/2004 | CN1520863A Formula and formulation of oral preparation for caring lung, maintaining appearance and invigorating the kidney using lily as main material |
| 08/18/2004 | CN1520849A Trauma pharmaceutical liquid spray |
| 08/18/2004 | CN1520848A Dermatophytosis liquid medicine |
| 08/18/2004 | CN1520811A External use composition containing oil-soluble licorice extract and its stabilization method |
| 08/18/2004 | CN1520807A Wound disinfection cleaning agent and method for making same |
| 08/18/2004 | CN1520792A Filling type fortified scar plaster and method for making same |
| 08/18/2004 | CN1162184C Methods and compositions for specific coagulation of vasculature |
| 08/18/2004 | CN1162181C Methods and composition for treatment of immunologically-mediated diseases using cow mycobacterium |
| 08/18/2004 | CN1162175C Chinese medicine composition for curing chloasma |
| 08/18/2004 | CN1162170C Leukoderma treating medicine and its preparation |
| 08/18/2004 | CN1162161C Staphylococcus aureus metabolin gel and its preparing process |
| 08/18/2004 | CN1162159C Compound heparin aqueogel and its preparing process |
| 08/17/2004 | US6777557 Method and composition for rejuvenating cells, tissues organs, hair and nails |
| 08/17/2004 | US6777544 Polyamide nucleic acid derivatives and agents and processes for preparing them |
| 08/17/2004 | US6777450 Non-phospholipid, non-ethoxylated ?pseudoemulsifier? having a chemical composition comprising at least one hydrophobic moiety, and at least one polar moiety |
| 08/17/2004 | US6777427 Tetrahydroquinoline compounds |